VBI Vaccines Inc logo

VBI Vaccines Inc

$ 0.71 -0.0233 (-3.2%) 04:00 PM EST
P/E:
At Loss
P/B:
1.74
Market Cap:
$ 185.00M
Enterprise V:
$ 139.22M
Volume:
395.26K
Avg Vol (2M):
1.17M
Also Trade In:
Volume:
395.26K
Market Cap $:
185.00M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.17M
Enterprise Value $:
139.22M
PB Ratio:
1.74
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Name Current Vs Industry Vs History
Cash-To-Debt 2.47
Equity-to-Asset 0.61
Debt-to-Equity 0.32
Debt-to-EBITDA -0.35
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.4
Distress
Grey
Safe
Beneish M-Score -4
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.09
9-Day RSI 36.37
14-Day RSI 37.74
6-1 Month Momentum % -48.03
12-1 Month Momentum % -70.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.29
Quick Ratio 2.19
Cash Ratio 2.03
Days Inventory 98.96
Days Sales Outstanding 41.03
Days Payable 128.03

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -38.4

Financials (Next Earnings Date:2022-11-08 Est.)

VBIV's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VBIV

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.66
EPS (TTM) ($) -0.39
Beta 2.43
Volatility % 48.38
14-Day RSI 37.74
14-Day ATR ($) 0.067364
20-Day SMA ($) 0.80383
12-1 Month Momentum % -70.74
52-Week Range ($) 0.6405 - 3.415
Shares Outstanding (Mil) 258.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

VBI Vaccines Inc Filings

Document Form Filing Date
No Filing Data

VBI Vaccines Inc Analysis

Share your research

Headlines

See More
No news.